# Enveric Biosciences, Inc.: Form 10-Q for the period ended Sep 30, 2015

- Company: [Enveric Biosciences, Inc.](/companies/envb.md) (CIK 890821)
- Form: 10-Q
- Filed: 2015-11-23
- Accepted by EDGAR: Nov 23, 2015, 15:58 ET
- Period: 2015-09-30
- Accession: 0001079974-15-000809
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/890821/000107997415000809/ameri10q9302015.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/890821/000107997415000809/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2015-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Cash and equivalents | at 2015-09-30 | $5.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2015-09-30 | $14.5m | us-gaap:AssetsCurrent |
| Total assets | at 2015-09-30 | $21.2m | us-gaap:Assets |
| Current liabilities | at 2015-09-30 | $14.8m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | at 2015-09-30 | $958.8k | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/890821/000107997415000809/ameri10q9302015.htm

Filed Nov 23, 2015.
Source: SEC EDGAR, the filing index for accession 0001079974-15-000809. Last ingested by Listed: Nov 14, 2026, 20:02 ET. No prices; not investment advice.
